Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
Public ClinicalTrials.gov record NCT00067093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients who have deep vein thrombosis (blood clot in the leg) will be treated in this study. The purpose of the study is to compare the safety and effectiveness of a new injectable anticoagulant (blood thinning) drug administered once each week, SanOrg34006, with the standard way of treating deep vein thrombosis. The standard treatment includes injections or infusions of an anticoagulant drug (Unfractionated Heparin or low molecular weight heparin) for about a week, followed by vitamin K antagonist (VKA) anticoagulant tablets (warfarin or acenocoumarol) which are taken by mouth. Eligible patients will be assigned to treatment with either SanOrg34006 or the combination of Unfractionated Heparin or low molecular weight heparin plus a VKA (warfarin or acenocoumarol) by random chance. Treatment will be known to both patients and their doctors.
Study identification
- NCT ID
- NCT00067093
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,452 participants
Conditions and interventions
Conditions
Interventions
- SanOrg34006 Drug
- LMW heparin Drug
- Unfractionated heparin Drug
- Vitamin K antagonist (VKA) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2003 (Type not available)
- Primary completion
- Sep 2005 (Actual)
- Completion
- Sep 2005 (Actual)
- Last update posted
- Apr 6, 2011
2003 – 2005
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado Health Sciences Center | Denver | Colorado | 80129 | — |
| Jackson Cardio-Vascular Clinic | Jacksonville | Florida | 32216 | — |
| MIMA Century Research Associates | Melbourne | Florida | 32901 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| DeKalb Medical Center | Decatur | Georgia | 30033-6136 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Evanston Northwestern Healthcare | Evanston | Illinois | 60201 | — |
| Loyola University of Chicago | Maywood | Illinois | 60513 | — |
| Consultants in Pulmonary Medicine | Olathe | Kansas | 66061 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| St. Joseph Mercy - Oakland Research Center | Pontiac | Michigan | 48341 | — |
| Lovelace Health Systems | Albuquerque | New Mexico | 87108 | — |
| North Shore University Hospital | Manhasset | New York | 11030 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Health System Research Center | Grand Forks | North Dakota | 58201 | — |
| University of Oklahoma HSC | Oklahoma City | Oklahoma | 73104 | — |
| Lehigh Valley Hospital | Allentown | Pennsylvania | 18103 | — |
| James Muntz | Houston | Texas | 77030 | — |
| Scott and White Memorial Hospital & Clinic | Temple | Texas | 76508 | — |
| Inova Alexandria Hospital | Alexandria | Virginia | 22304 | — |
| Pulmonary Associates | Fredericksburg | Virginia | 22401 | — |
| McGuire VAMC | Richmond | Virginia | 23249 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
| William Dittman | Spokane | Washington | 99203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00067093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2011 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00067093 live on ClinicalTrials.gov.